When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Myocarditis

Last reviewed: 8 Aug 2025
Last updated: 03 Jul 2024

Summary

Definition

History and exam

Key diagnostic factors

  • viral syndrome (prior)
  • autoimmune disease
  • infectious disease
  • drugs and toxins
Full details

Other diagnostic factors

  • age <50 years
  • chest pain
  • dyspnea
  • orthopnea
  • fatigue
  • palpitations
  • rales
  • elevated neck veins
  • S3 gallop
  • sinus tachycardia
  • atrial and ventricular arrhythmias
  • tachypnea
  • hepatomegaly
  • syncope
  • fever
  • gastrointestinal issues
  • rhinorrhea
  • cough
  • S3 and S4 summation gallop
  • pericardial friction rub
  • peripheral hypoperfusion
  • hypotension
  • altered sensorium
  • lymphadenopathy
  • respiratory distress
Full details

Risk factors

  • infection (non-HIV)
  • HIV infection
  • autoimmune/immune-mediated diseases
  • peripartum and postpartum periods
  • drugs and toxins
Full details

Diagnostic tests

1st tests to order

  • 12-lead ECG
  • CXR
  • serum CK
  • serum CK-MB
  • serum troponin (I or T)
  • serum B-type natriuretic peptide
  • two-dimensional echocardiogram
Full details

Tests to consider

  • endomyocardial biopsy (EMB)
  • coronary angiography
  • 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT)
  • cardiac MRI
  • viral polymerase chain reaction (PCR)
Full details

Emerging tests

  • MRI-guided EMB

Treatment algorithm

ACUTE

hemodynamically stable: no evidence of LV systolic dysfunction

hemodynamically stable: evidence of LV systolic dysfunction

hemodynamically unstable: adults

hemodynamically unstable: children

ONGOING

end-stage heart failure or refractory life-threatening arrhythmias

Contributors

Authors

Shriprasad R. Deshpande, MBBS, MS

Medical Director

Heart Transplant and Advanced Cardiac Therapies Program

Children's National Hospital

Associate Professor of Pediatrics

The George Washington University

Washington

DC

Disclosures

SRD declares that he has no competing interests.

Bibhuti Das, ​MBBS, MD, FAAP, FACC

Director of Heart Failure and Heart Transplant

Pediatric Cardiology

University of Mississippi Medical Center

Jackson

MS

Disclosures

BD declares that he has no competing interests.

Acknowledgements

Dr Shriprasad R. Deshpande and Dr Bibhuti Das would like to gratefully acknowledge Dr Katherine C. Wu, Dr James E. Harvey, and Dr Arman T. Askari, previous contributors to this topic. KCW, JEH, and ATA declare that they have no competing interests.

Peer reviewers

David A. Leaf, MD, MPH

Professor of Medicine

School of Medicine

VA Greater Los Angeles Healthcare System

UCLA

Los Angeles

CA

Disclosures

DAL declares that he has no competing interests.

John Charpie, MD, PhD

Associate Professor of Pediatrics

Medical Director

Pediatric Cardiothoracic Intensive Care Unit

University of Michigan Congenital Heart Center

Ann Arbor

MI

Divulgaciones

JC declares that he has no competing interests.

Lokesh Tejwani, MD, FACC

Assistant Professor of Clinical Medicine

University of Missouri Hospitals and Clinics

Harry S. Truman VA Hospital

Columbia

MO

Divulgaciones

LT declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Lieberman EB, Hershkowitz A, Rose NR, et al. A clinicopathologic description of myocarditis. Clin Immunol Immunopathol. 1993 Aug;68(2):191-6. Resumen

Law YM, Lal AK, Chen S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation. 2021 Aug 10;144(6):e123-35.Texto completo  Resumen

Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016 Nov 3;134(23):e579-646.Texto completo  Resumen

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-1032.Texto completo  Resumen

Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Myocarditis images
  • Diferenciales

    • Acute coronary syndrome
    • Dilated cardiomyopathy
    • Pericarditis
    Más Diferenciales
  • Guías de práctica clínica

    • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    • 2022 ESC Guidelines on cardio-oncology
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad